Eltrombopag with i.v. immunoglobulin for safe splenectomy in refractory immune thrombocytopenia

Pediatr Int. 2018 Feb;60(2):191-192. doi: 10.1111/ped.13446. Epub 2017 Dec 22.

Authors

Miyako Kanno¹, Tadashi Onoda¹, Tohru Meguro¹, Hiroko Sato¹, Tetsuo Mitsui¹

Affiliation

¹ Department of Pediatrics, Yamagata University School of Medicine, Yamagata, Japan.

PMID: 29271533
DOI: 10.1111/ped.13446

No abstract available

Keywords: children; immune thrombocytopenia; refractory; splenectomy; thrombopoietin receptor agonist.

Publication types

Case Reports

MeSH terms

Benzoates / therapeutic use*
Child, Preschool
Combined Modality Therapy
Drug Therapy, Combination
Female
Humans
Hydrazines / therapeutic use*
Immunoglobulins, Intravenous / therapeutic use*
Immunologic Factors / therapeutic use*
Purpura, Thrombocytopenic, Idiopathic / therapy*
Pyrazoles / therapeutic use*
Splenectomy*

Substances

Benzoates
Hydrazines
Immunoglobulins, Intravenous
Immunologic Factors
Pyrazoles
eltrombopag